![Thomas Andrew Davis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Andrew Davis
Plus aucun poste en cours
Profil
Thomas Andrew Davis worked as a Senior Director-Clinical Science at Medarex, Inc. from 2001 to 2003.
He then worked as the Chief Medical Officer at GenVec, Inc. in 2005.
In 2006, he became the Chief Medical Officer & VP-Clinical Development at Celldex Research Corp.
and later became the Chief Medical Officer & Executive Vice President at Celldex Therapeutics, Inc. from 2014 to 2017.
In 2008, he briefly worked as the Chief Medical Officer & Senior Vice President at AVANT Immunotherapeutics, Inc. He then worked as the Chief Medical Officer at Gadeta BV from 2017 to 2018.
From 2018 to 2022, he worked as the Chief Medical Officer at Genocea Biosciences, Inc. Dr. Davis received his undergraduate degree from The Johns Hopkins University and his graduate and doctorate degrees from Georgetown University.
Anciens postes connus de Thomas Andrew Davis
| Sociétés | Poste | Fin |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 20/05/2022 |
Gadeta BV
 Gadeta BV BiotechnologyHealth Technology Conducts research and develops medicines & treatment methods for cancer | Directeur Technique/Scientifique/R&D | 01/04/2018 |
| CELLDEX THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2017 |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Directeur Technique/Scientifique/R&D | 01/10/2008 |
Celldex Research Corp.
 Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Directeur Technique/Scientifique/R&D | 01/03/2008 |
Formation de Thomas Andrew Davis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Celldex Research Corp.
Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Commercial Services |
Gadeta BV
Gadeta BV BiotechnologyHealth Technology Conducts research and develops medicines & treatment methods for cancer | Health Technology |
